Laurence J C van Warmerdam
Overview
Explore the profile of Laurence J C van Warmerdam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
106
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schipper R, de Bruijn A, van der Sangen M, Bloemen J, van den Hoven I, Schepers E, et al.
Eur J Surg Oncol
. 2024 Jun;
50(9):108472.
PMID: 38870876
Background: The aim of the present study was to report the 5-year axillary recurrence-free interval (aRFI) in clinically node-positive breast cancer patients treated according to a de-escalating axillary treatment protocol...
2.
de Groot S, Pijl H, Charehbili A, van de Ven S, Smit V, Meershoek-Klein Kranenbarg E, et al.
Breast Cancer Res
. 2019 Aug;
21(1):97.
PMID: 31455425
Background: Adjuvant bisphosphonates are associated with improved breast cancer survival in postmenopausal patients. Addition of zoledronic acid (ZA) to neoadjuvant chemotherapy did not improve pathological complete response in the phase...
3.
Claessens A, Bos M, Lopez-Yurda M, Bouma J, Rademaker-Lakhai J, Honkoop A, et al.
Breast Cancer Res Treat
. 2018 Aug;
172(2):413-423.
PMID: 30121808
Purpose: We determined if intermittent first-line treatment with paclitaxel plus bevacizumab was not inferior to continuous treatment in patients with HER2-negative, advanced breast cancer. Methods: Patients were randomized to 2 ...
4.
Vugts G, Van den Heuvel F, Maaskant-Braat A, Voogd A, van Warmerdam L, Nieuwenhuijzen G, et al.
Breast J
. 2018 Jul;
24(6):894-901.
PMID: 30033607
Purpose: Neoadjuvant systemic treatment (NST) is increasingly administered in breast cancer patients. This study was conducted to identify predictors for tumor response in the breast and axilla. Methods: All female...
5.
Vriens B, de Vries B, Lobbes M, van Gastel S, van den Berkmortel F, Smilde T, et al.
Eur J Cancer
. 2015 Dec;
52:67-76.
PMID: 26650831
Background: The aim of this study was to evaluate the accuracy of clinical imaging of the primary breast tumour post-neoadjuvant chemotherapy (NAC) related to the post-neoadjuvant histological tumour size (gold...
6.
Slingerland M, Guchelaar H, Rosing H, Scheulen M, van Warmerdam L, Beijnen J, et al.
Clin Ther
. 2013 Dec;
35(12):1946-54.
PMID: 24290734
Background: Preclinical studies comparing paclitaxel formulated with polyethoxylated castor oil with the sonicated formulation of liposome-entrapped paclitaxel (LEP) have demonstrated that LEP was associated with reduced toxicity while maintaining similar...
7.
Pullens M, de Vries J, van Warmerdam L, van de Wal M, Roukema J
Psychooncology
. 2012 Oct;
22(8):1783-9.
PMID: 23109296
Background: Results of existing studies are inconclusive concerning the relationship between chemotherapy and subjective cognitive functioning (SCF). The aim of this study was to evaluate SCF of breast cancer (BC)...